Supplementary Information
Supplementary Table 1 A panel of anti--CD20 heavy chains were co--expressed with a panel of anti--CD3 light chains, and supernatants from transient transfections were evaluated for binding to Raji (CD20+) cells by flow cytometry. Antibodies showing at least a 3--fold signal above background binding to control CD20--negative cells (Jurkat, HEK293) were scored as +, while those showing lower levels of binding were scored +/--, and those showing no binding above background were scored as negative (NT = not tested). We observed that several heavy chains (CD20--1 and CD20--3) retained the ability to bind CD20 when paired with most of the non--cognate light chains tested, and we therefore selected these heavy chains for further characterization.
Supplementary Figure 1 The CD20--1 /CD3--11 heavy chain/light chain pair identified as described in Supplementary Table 1 was purified and compared to the purified parental anti--CD20 antibody by flow cytometry, as described in Methods. This non--cognate heavy/light chain pairing demonstrated similar binding affinity to Raji (CD20+) cells by FACS when compared to the parental. As expected, no binding was observed with the parental anti--CD3 antibody. The CD20--1 heavy chain, combined with the CD3--11 heavy and light chains, were therefore chosen to generate a CD20xCD3 bispecific.
Supplementary Methods

Characterization of CD20 Heavy Chain/CD3 Light Chain hybrid antibodies
To generate hybrid antibodies, CHO--K1 cells were transiently transfected with a ratio of 3:1 light chain to heavy chain plasmid DNA, using standard Lipofectamine protocols. After culturing for an additional 72--96 hr, supernatants were collected.
To assess binding to CD20, 20 ul of supernatant was incubated with cells (Raji, Jurkat or HEK293 cells) for 45 minutes at 4 0 C. The cells were then washed, incubated with the secondary anti--Human PE for an additional 30 minutes at 4 0 C, washed again and then resuspended for analysis. The geometric mean fluorescence (MFI) of stained cells was measured using a BD FACS Canto II flow cytometer.
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